Below is the team behind the 2015 reanalysis, Restoring Study 329, including details of their role in the study.
Joanna Le Noury, PhD
Senior Research Psychologist
Lead author on Restoring Study 329; data collection and analysis of 34% of 77,000 pages of de-identified individual case report forms (CRFs) made available through GSK online remote system, analysis and interpretation of harms data (Appendix D).
John M. (Mickey) Nardo, M.D., B.S. (Mathematics)
Retired Physician and Professor
Detailed analysis of original Study 329 data; Active lobbyist for retraction of Study 329. Conception/design of the RIAT approach; Extraction of efficacy data using GSK online remote system; statistical analysis of efficacy data.
David Healy, M.D. FRCPsych
Professor of Psychiatry
Conception/design of the work; interpretation of harms data.
Jon Jureidini, PhD, MB BS, FRANZCP
Professor of Psychiatry
One of the original critics of methodology by original Study 329 team, Conception/design of the work; Acquisition of data through negotiation with GSK; RIAT team point person with BMJ for keeping progress/edits on track; study guarantor.
Melissa Raven, PhD
Psychiatric Epidemiologist
Analysis of protocol and ensuring conformity of rewrite to original protocol; construction of the RIAT audit record.
Catalin Tufanaru, M.D., MPH, MClinSci (EBHC)
Research Associate
Analysis of protocol and ensuring conformity of rewrite to original protocol; construction of the RIAT audit record.
Elia Abi-Jaoude, MD, FRCP(C)
Psychiatrist
Analysis of protocol and ensuring conformity of rewrite to original protocol; construction of the RIAT audit record.